Clinical Trials Browser

Phase 4 × Neoplasms × Plasma cell × Clear all

Acquired Immunodeficiency Syndrome, Diabetes Mellitus, Type 2, Hypergammaglobulinemia, Multiple Sclerosis, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT06251076 2025-12-10

Plan Development for Giving Teclistamab in the Outpatient Setting

Phase 4 Recruiting

15 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Recurrence

NCT07025005 2025-11-04

VRd MM Fibrate

Phase 4 Recruiting

44 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT01410929 2017-01-20

MM

Phase 4 Withdrawn

Plasma cell

Back Pain, Multiple Myeloma, Neoplasms

Clinical Trials

EREVA

Plan Development for Giving Teclistamab in the Outpatient Setting

VRd MM Fibrate

MM